-
1
-
-
84894191167
-
-
Available
-
Migration Information Source, Available: http://www.migrationinformation. org/feature/display.cfm?ID=402
-
-
-
-
3
-
-
84894165672
-
-
Available
-
VPH-SHARE, Available: http://www.vph-share.eu/
-
-
-
-
7
-
-
84894118181
-
-
http://www-03.ibm.com/press/us/en/pressrelease/22375.wss
-
-
-
-
8
-
-
84894177620
-
-
Available
-
HealthVault, Available: https://www.healthvault.com/gr/en
-
-
-
-
9
-
-
70350381719
-
-
Available
-
Google Health, Available: http://en.wikipedia.org/wiki/Google-Health
-
Google Health
-
-
-
10
-
-
84894148078
-
-
Available
-
Zygote Body, Available: http://www.zygotebody.com/
-
-
-
-
13
-
-
67649392513
-
A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates
-
M. Jamei, G. L. Dickinson, and A. Rostami-Hodjegan, "A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates", Drug Metab Pharmacokinet, vol. 24, 2009, pp. 53-75.
-
(2009)
Drug Metab Pharmacokinet
, vol.24
, pp. 53-75
-
-
Jamei, M.1
Dickinson, G.L.2
Rostami-Hodjegan, A.3
-
14
-
-
13244287685
-
'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions
-
DOI 10.1016/j.ddtec.2004.10.002, PII S174067490400037X
-
A. Rostami-Hodjegan and G. Tucker, " "In silico" simulations to assess the "in vivo" consequences of "in vitro" metabolic dru-drug interactions", Drug Discovery Today: Technologies, vol. 1, 2004, pp. 441-448. (Pubitemid 40186348)
-
(2004)
Drug Discovery Today: Technologies
, vol.1
, Issue.4
, pp. 441-448
-
-
Rostami-Hodjegan, A.1
Tucker, G.2
-
15
-
-
33751219856
-
In silico prediction of clinical efficacy
-
S. Michelson, A. Sehgal, and C. Friedrich, "In silico prediction of clinical efficacy," Curr Opin Biotechnol, vol. 17, 2006, pp. 666-70.
-
(2006)
Curr Opin Biotechnol
, vol.17
, pp. 666-670
-
-
Michelson, S.1
Sehgal, A.2
Friedrich, C.3
-
16
-
-
0037364162
-
ADMET in silico modelling: Towards prediction paradise?
-
DOI 10.1038/nrd1032
-
H. van de Waterbeemd and E. Gifford, "ADMET in silico modelling: towards prediction paradise?" Nat Rev Drug Discov, vol. 2, 2003, pp. 192-204. (Pubitemid 37361664)
-
(2003)
Nature Reviews Drug Discovery
, vol.2
, Issue.3
, pp. 192-204
-
-
Van De, W.H.1
Gifford, E.2
-
17
-
-
77954051808
-
-
National Institute of Science and Technology
-
P. Mell and T. Grance. The NIST Definition of Cloud Computing. National Institute of Science and Technology. http://csrc.nist.gov/publications/nistpubs/ 800-145/SP800-145.pdf
-
The NIST Definition of Cloud Computing
-
-
Mell, P.1
Grance, T.2
|